This Week in Psychedelics - 5.28.21

Cannabis

• New York bans delta-8 THC, resists calls to track hemp like marijuana (Marijuana Business Daily)

• Legal Marijuana States Have Generated Nearly $8 Billion In Tax Revenue Since Recreational Sales Launched, Report Finds (Marijuana Moment)

• Minnesota: Governor Signs Legislation into Law to Legalize Medical Marijuana Flower (NORML)

• Nevada: Lawmakers Send Multiple Marijuana Reform Measures to Governor’s Desk (NORML)

• Cannabis emoji remains elusive: When it will exist, what it might look like, and why we don’t have one (yet) (GreenState)

• Louisiana: House-Approved Marijuana Decriminalization Bill Heads to Senate Floor (NORML)

• The Decriminalization of Marijuana in Brazil Beyond the Medicinal Use: Cannabis Associations and Human Rights (Chacruna)

• Atheists Are Much More Likely To Back Marijuana Legalization Than Christians Are, New Poll Finds (Marijuana Moment)

LSD

• Microdosing Psilocybin and LSD: Panacea or Placebo? (Spirit Pharmacist)

• MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing (Psilocybin Alpha)

Magic Mushrooms

• Attorneys General Back Doctor on DEA Psilocybin Lawsuit (Truffle Report)

• Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms (Psilocybin Alpha)

• María Sabina, Mushrooms, and Colonial Extractivism (Chacruna)

• The Psilocybin vs. Escitalopram Trial – Part 1 (Psychedelic Science Review)

MDMA

• The Effects of MDMA on Liver Health (Truffle Report)

DMT

• Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke (Psilocybin Alpha)

Ayahuasca

• When Ayahuasca Microdosing Might Cause Serotonin Toxicity (Chacruna)

• Breathe Easy: Combining Albuterol & Ayahuasca (Spirit Pharmacist)

Iboga

• Why Iboga Is Considered a Master Healer (Lucid News)

Novel Psychoactive Substances

• Non-hallucinogenic psychedelic analog reverses effects of stress in mouse study (Science Daily)

Nitrous Oxide

• London borough bans ‘laughing gas’ nitrous oxide over anti-social behaviour (The Independent)

Ketamine

• Effort to limit ketamine use by Colorado paramedics, police advances toward governor’s desk (The Colorado Sun)

• PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease (Psilocybin Alpha)

• PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations (Psilocybin Alpha)

Miscellaneous

• Texas Senate Approves Psychedelics And Marijuana Concentrates Bills (Marijuana Moment)

• Maine Lawmakers Advance Drug Decriminalization Bill To House Floor With Conflicting Recommendations (Marijuana Moment)

• Psychedelics’ Exciting Potential to Benefit Autistic People (Filter)

• Virtual Reality and Psychedelic Synergy (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.5.21

Cannabis

• Virginia Lawmakers Vote to Legalize Marijuana in 2024 (TIME)

• Mexican Lawmakers To Vote On Marijuana Legalization Next Week (Marijuana Moment)

• Morocco Expected To Pass Cannabis Legalization Soon (High Times)

• New Mexico House Approves Marijuana Legalization Bill, With Senate Action Imminent (Marijuana Moment)

• Hawaii Marijuana Legalization Bill Heads To Senate Floor, Along With Separate Measure To Expand Decriminalization (Marijuana Moment)

• Third Minnesota House Committee Approves Marijuana Legalization Bill (Marijuana Moment)

• Tennessee Senators Approve Medical Marijuana Bill In Committee (Marijuana Moment)

• Alabama Senators Approve Marijuana Decriminalization Bill In Committee (Marijuana Moment)

• Washington, D.C. Could Allow Marijuana Sales Under Mayor’s New Bill And Democratic Control Of Congress (Marijuana Moment)

• Top Washington, D.C. Lawmaker Files Competing Legal Marijuana Bill Days After Mayor Unveils Her Plan (Marijuana Moment)

• Montana: Lawmakers Seek to Amend Voter-Approved Marijuana Legalization Law (NORML)

• Mississippi House Replaces Senate’s Alternate Medical Marijuana Program With What Voters Originally Approved (Marijuana Moment)

• 'I really love weed': Seth Rogen brings his cannabis company, Houseplant, to U.S. (NBC News)

• Study Indicates Most Patients Don’t Think Doctors Will Understand Cannabis (High Times)

• Pennsylvania Governor Grants 69 Marijuana Pardons As Lawmakers Move Bipartisan Legalization Bill (Marijuana Moment)

• Iowa Senators Approve Bill To Reduce Marijuana Penalties (Marijuana Moment)

• Review study: Cannabis and driving cognition (Marijuana Business Daily)

• Illinois city uses weed sales tax for reparations (Leafly)

• Marijuana Legalization Could Curb West Virginia’s Overdose Crisis, Governor Says (Filter)

• Decline In Banks Working With Marijuana Businesses Has ‘Leveled Off,’ New Federal Data Shows (Marijuana Moment)

• A New Observational Study Focusing On Cannabis For PTSD Treatment Has Been Approved (Forbes)

• Prisons should trial free cannabis, says UK's former chief drug adviser (The Guardian)

• Connecticut Polls Shows Majority Support For Marijuana Legalization And Expungements As Lawmakers Consider Reform (Marijuana Moment)

• Texas Voters’ Support For Legalizing Marijuana Is Increasing, New Poll Shows (Marijuana Moment)

LSD

• Benefits of microdosing LSD might be placebo effect, study finds (The Guardian)

• Can Psilocybin and LSD Relieve Existential Suffering? (Psychedelic Science Review)

• DEA: 'We've seen a very large increase in LSD' (KABB)

Magic Mushrooms

• Iowa Lawmakers Hold Historic Hearing On Psilocybin Decriminalization, But Do Not Advance Bill (Marijuana Moment)

• TheraPsil Launches Psilocybin Therapy Training Program (Truffle Report)

• Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin (BioSpace)

• PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization (Psilocybin Alpha)

• MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin (Psilocybin Alpha)

• Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update (Psilocybin Alpha)

MDMA

• Promise and challenges for psilocybin and MDMA use in treatment (Peter Attia MD)

DMT

• A Beginner’s Guide to DMT Vape Pens (Truffle Report)

• Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK) (Psilocybin Alpha)

Ayahuasca

• Mail Order Ayahuasca Is Now A Thing (DoubleBlind)

• How Colombian Yagé Communities Confronted the COVID-19 Pandemic (Chacruna)

• Ayahuasca In the Fight Against Drug Addiction (CBD Testers)

5-MeO-DMT

• A Beginner’s Guide to Psychedelic Amphibians (Truffle Report)

Iboga

• MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research (PR Newswire)

• MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury (Psilocybin Alpha)

Synthetic Cannabinoids

• Drug Testing and Synthetic Cannabis in Prisons (Drug Science)

• Dangerous batch of synthetic cannabis may be behind Christchurch death (Stuff.co.nz)

Ketamine

• PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease (GlobeNewswire)

• Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial (Psilocybin Alpha)

Miscellaneous

• Washington State Supreme Court finds state's felony drug possession law unconstitutional (Q13 Fox)

• U.S. Tells Mexico Drug War’s Failure Requires New Strategy (Bloomberg)

• Sewage Samples Reveal the Dutch, Australians Are Biggest Users of Synthetic Drugs (VICE)

• Canada’s Government Moves To End Mandatory Minimums For Drugs, But Voters Back Full Decriminalization (Marijuana Moment)

• Want To Take A Psychedelic Trip Without Drugs? There’s Now An App For That (Forbes)

• European companies set to dominate psychedelics market (Sifted)

• Online Psychedelic Community Options to Ride Out the Rest of Covid-19 (Psychedelics Today)

• Are Natural Psychedelics Or Synthetic Psychedelics Better For Your Body? (Healing Maps)

• CryptoPsychedelic Conferences Examine Links Between Psychedelics and Blockchain Technology (Lucid News)

• Psychedelics and Environmental Sustainability (Truffle Report)

• Growing popularity of therapeutic psychedelic experiences creates demand for underground guides (CBC)

• Investing In Psychedelics: Why Is It In Such High Demand These Days? (Healing Maps)

• Most People With Addiction Outgrow It Naturally. We Need to Hear Them. (Filter)

• Finding the Psychedelic Sweet Spot (Psychedelic Science Review)

• Does Animal Consciousness Expand From Psychedelics Too? (Reality Sandwich)

• Best Practices For Tripsitters (Maps of the Mind)

• What Effects Do Psychedelics Have on Social Perception? (Truffle Report)

• Christian Siriano’s Psychedelic Trip (The Cut)

• Red Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert (Psilocybin Alpha)

• Growing interest in psychedelic treatments for mental illness, but expert warns more robust research needed (CBC)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.